BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessAbeona Therapeutics to Present at Multiple Upcoming ConferencesBy Nasdaq OMXMay 19, 2017, 12:06 PM UTC
BusinessAbeona Therapeutics to Present at Multiple Upcoming ConferencesBy Nasdaq OMXMay 19, 2017, 12:06 PM UTC
